Evidence map›Paper›PMID 40811449›Full record

ArticlePloS one2025

Seroprevalence of antibodies against hepatitis A and E among the general population in 5 provinces, Lao People's Democratic Republic: Variation according to location.

Vilaysone Khounvisith, Siriphone Virachith, Nouna Innoula, Latdavone Khenkha, Bounta Vongphachanh, Jan Hattendoft, Peter Odermatt, Judith M Hübschen, Antony P Black

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vilaysone KhounvisithLaoLuxLab/Vaccine Preventable Diseases Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.ORCID https://orcid.org/0009-0000-7251-4973
Siriphone VirachithLaoLuxLab/Vaccine Preventable Diseases Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.ORCID https://orcid.org/0000-0001-5049-0544
Nouna InnoulaLaoLuxLab/Vaccine Preventable Diseases Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.
Latdavone KhenkhaLaoLuxLab/Vaccine Preventable Diseases Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.
Bounta VongphachanhLaoLuxLab/Vaccine Preventable Diseases Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.
Jan HattendoftSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Peter OdermattSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Judith M HübschenDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Grand-Duchy of Luxembourg.
Antony P BlackLaoLuxLab/Vaccine Preventable Diseases Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.ORCID https://orcid.org/0000-0003-0579-0702

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis A and E viruses (HAV and HEV) are transmitted through the faecal-oral route: via contaminated food, water, and contact with infected people and/or animals for HEV. Due to limited data from Lao People's Democratic Republic (Lao PDR), we assessed HAV and HEV seroprevalence in the Lao general population. A cross-sectional study collected 2412 serum samples and demographic information from participants (5-93 years) across five provinces. Anti-HAV (IgM and IgG) and anti-HEV antibodies (IgG) were detected by enzyme-linked immunosorbent assay (Dia.Pro). The overall seroprevalence of anti-HAV was 84.3% and anti-HEV was 57.9%. Seropositivity was associated with occupation, location, increasing age, ethnicity (only for anti-HAV) and sex (only for anti-HEV). The age at which 50% of the population was seropositive differed from 12 years (Oudomxay) to 26 years (Savannakhet and Vientiane) for anti-HAV and from 22 years (Savannakhet) to 49 years (Vientiane) for anti-HEV. The prevalence of double seropositivity was high overall (53.4%), particularly in Savannakhet and Champasack. These significant differences according to location and socio-demographics may be the result of variation of exposure to the viruses, such as through water, sanitation and hygiene-related risks, occupational exposure and animal contact. Further studies are warranted to identify the most important risks for transmission in Lao PDR in order to develop targeted public health interventions.

Indexed as

Hepatitis AHepatitis A AntibodiesHepatitis AntibodiesHepatitis A virusHepatitis EHepatitis E virusAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCross-Sectional StudiesFemaleHumansImmunoglobulin GHepatitis A AntibodiesHepatitis AntibodiesImmunoglobulin G

Identifiers

PMID40811449
PMCPMC12352656

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.